Last updated: April 19, 2026

Application No. 18/147,365

RNA ENCODING AN ANTIBODY

Non-Final OA

Filed

Dec 28, 2022

Examiner

BURKHART, MICHAEL D

Art Unit

1638

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

CUREVAC SE

OA Round

1 (Non-Final)

Interview Optional

— +9.9% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 811 resolved cases, 2023–2026

Examiner Intelligence

BURKHART, MICHAEL D View full profile →

Grants 62% of resolved cases

Career Allow Rate

507 granted / 811 resolved

+2.5% vs TC avg

Moderate +10% lift

Without

With

+9.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

45 currently pending

Career history

856

Total Applications

across all art units

Statute-Specific Performance

§101

3.8%

-36.2% vs TC avg

§103

27.5%

-12.5% vs TC avg

§102

21.0%

-19.0% vs TC avg

§112

25.2%

-14.8% vs TC avg

Black line = Tech Center average estimate • Based on career data from 811 resolved cases

Prosecution Timeline

Dec 28, 2022

Application Filed

Oct 18, 2025

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/477,491

Patent 12600796

NOVEL CONSTRUCTS FOR CHIMERIC ANTIGEN RECEPTORS

2y 5m to grant Granted Apr 14, 2026

19/070,308

Patent 12595460

Method and Apparatus for Producing CAR T Cells

2y 5m to grant Granted Apr 07, 2026

17/309,209

Patent 12590148

METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY

2y 5m to grant Granted Mar 31, 2026

17/285,440

Patent 12577546

PROGRAMMABLE DNA BASE EDITING BY NME2CAS9-DEAMINASE FUSION PROTEINS

2y 5m to grant Granted Mar 17, 2026

17/908,712

Patent 12565675

METHOD FOR SELECTING APTAMERS WITH HIGH TARGET SPECIFICITY IN A MICROFLUIDIC DEVICE PLATFORM FOR CO-CULTURE OF MULTIPLE TISSUES

2y 5m to grant Granted Mar 03, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

62%

Grant Probability

72%

With Interview (+9.9%)

3y 3m

Median Time to Grant

Low

PTA Risk

Based on 811 resolved cases by this examiner. Grant probability derived from career allow rate.